RESUMEN
A new mesoporous Mn(II)-MOF [Mn2(phen)2(nia)2]∞ with 4-c uninodal net topology and reiterating rectangular channels in its cargo-net like extension was synthesized using π-conjugated phenanthroline (phen) and syn-syn bridging 5-nitroisopthalic acid (nia) linkers. The MOF (1) exhibited phase purity, uniform morphology, photo and thermal stability, and robustness; duly triggered by the exceptional framework rigidity via intermolecular H-bonding and interlayer π-π stacking interactions. The bright-blue luminescence of the MOF nano-dispersion was explored for sensitive, specific and ultrafast detection of trinitrophenol (TNP) with extremely low LOD (90.62â nM), high KSV (18.27×104â M-1) and Kq (4×1014â M-1s-1). The vapor-phase TNP sensing was also accomplished. Additionally, 1 served towards discriminatory, aqueous-phase monitoring of Cr(VI)-oxoanions, depicting LODs: 36.08 and 35.70 ppb; KSV: 3.46×104 and 4.87×104â M-1; Kq: 3.26×1013â M-1s-1 and 4.31×1013â M-1s-1; and response time: 32 and 40s for CrO4 2- and Cr2O7 2- respectively. The quenching mechanisms (i. e., RET, PET, IFE, weak interactions, collisional quenching and πâ â â π stacking) was explained from several experimental investigations and theoretical DFT calculations. The recyclable sensing events and quantification from complex environmental matrices with admirable recovery rates and high KSV (13.02-22.44×104; ~6.31-10.98×104 and ~6.60-11.42×104â M-1 for TNP, CrO4 2- and Cr2O7 2-) undoubtedly advocated the consistency of the probe.
RESUMEN
Infectious bacterial biofilms are recalcitrant to most antibiotics compared to their planktonic version, and the lack of appropriate therapeutic strategies for mitigating them poses a serious threat to clinical treatment. A ternary heterojunction material derived from a Bi-based perovskite-TiO2 hybrid and a [Ru(2,2'-bpy)2(4,4'-dicarboxy-2,2'-bpy)]2+ (2,2'-bpy, 2,2'-bipyridyl) as a photosensitizer (RuPS) is developed. This hybrid material is found to be capable of generating reactive oxygen species (ROS)/reactive nitrogen species (RNS) upon solar light irradiation. The aligned band edges and effective exciton dynamics between multisite heterojunctions are established by steady-state/time-resolved optical and other spectroscopic studies. Proposed mechanistic pathways for the photocatalytic generation of ROS/RNS are rationalized based on a cascade-redox processes arising from three catalytic centers. These ROS/RNS are utilized to demonstrate a proof-of-concept in treating two elusive bacterial biofilms while maintaining a high level of biocompatibility (IC50 > 1 mg/mL). The in situ generation of radical species (ROS/RNS) upon photoirradiation is established with EPR spectroscopic measurements and colorimetric assays. Experimental results showed improved efficacy toward biofilm inactivation of the ternary heterojunction material as compared to their individual/binary counterparts under solar light irradiation. The multisite heterojunction formation helped with better exciton delocalization for an efficient catalytic biofilm inactivation. This was rationalized based on the favorable exciton dissociation followed by the onset of multiple oxidation and reduction sites in the ternary heterojunction. This together with exceptional photoelectric features of lead-free halide perovskites outlines a proof-of-principle demonstration in biomedical optoelectronics addressing multimodal antibiofilm/antimicrobial modality.
Asunto(s)
Biopelículas , Bismuto , Bismuto/farmacología , Bismuto/química , Especies Reactivas de OxígenoRESUMEN
Recently, the low-dimensional organic-inorganic halide perovskites (OIHP) have been exploited heavily for their favorable exciton dynamics, broad-band emission, remarkable stability, and tunable band-edge excited-state energy compared to their 3D counterparts for potential optoelectronic applications. Low-dimensional perovskites are generally good candidates for utilization as room-temperature photoluminescence (PL) materials. Further, doping divalent transition metals like Mn2+ into OIHP is expected to introduce a 4T1-6A1-based low-energy luminescence emission around 600 nm; an optical property that is favorable for biomedical optoelectronics. Doping Mn2+ in the perovskite lattice is also expected to induce the generation of cytotoxic singlet oxygen species (1O2), a ROS that is being exploited for various therapeutic applications. To integrate these optical and therapeutic properties of a 2D (PEA)2PbBr4 (Pb PeV; PEA = phenylethylammonium cation) perovskite alloyed with Mn2+ ions (Mn:PbPeV) and the option for a photoinduced energy transfer process involving a Cr(III)-based 1O2 generating photosensitizer (CrPS), we designed a unique purpose-built nanoassembly (Mn:PbPeV@PCD) using the encapsulation properties of a water-soluble polymer derived from ß-cyclodextrin (PCD). Here the PCD is observed to modulate the classical internal energy transfer of Pb2+ exciton to alloyed Mn2+ orange emission, resulting in the emergence of a new blue emission. The addition of CrPS into the Mn:PbPeV@PCD to generate the CrPS@Mn:PbPeV@PCD assembly results in restoring perovskite luminescence followed by the external energy transfer to CrPS. We have elucidated the mechanism of these cascade energy transfer processes between multiple components using steady-state and time-resolved luminescence techniques. Efficient ROS generation and its potential to induce an oxidation reaction of a biomolecule are realized using guanine as the target molecule. Further photoinduced cleavage studies with biomolecules confirmed the efficacy of the nanoassembly in inducing the cleavage of guanine-rich DNA. The study opens up a new direction in the field of perovskite for biomedical applications.